LP
CVAC

LMR Partners’s CureVac CVAC Stock Holding History

LMR Partners’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-109,360
Closed -$659K – 1057
2022
Q4 		$659K Buy
+109,360
New +$808K 0.01% 807

Other funds holding CVAC

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

LMR Partners's CVAC Position: Q1 2023 in Review

LMR Partners sold out of CureVac (CVAC) in Q1 2023, closing a stake of 109,360 shares — an estimated $659K sold.

LMR Partners first reported a position in CVAC in Q4 2022 and held it in 1 quarter. The position peaked at $659K in Q4 2022. 82 funds tracked by Wall St. Rank hold CVAC as of Q1 2023.

  • LMR Partners reported no remaining CureVac position as of Q1 2023 after selling out during the quarter.
  • LMR Partners sold 109,360 CureVac shares in Q1 2023, an estimated $659K.
  • LMR Partners first reported a position in CureVac in Q4 2022 and held it in 1 quarter.
  • LMR Partners's CureVac position peaked at $659K in Q4 2022.
  • 82 funds tracked by Wall St. Rank held CureVac as of Q1 2023.

Based on LMR Partners's 13F filing for Q1 2023, filed 15 May 2023.